Acute Arterial Thrombosis during Postoperative Adjuvant Cisplatin-based Chemotherapy for Completely Resected Lung Adenocarcinoma

Intern Med. 2018 Feb 15;57(4):557-561. doi: 10.2169/internalmedicine.8996-17. Epub 2017 Dec 8.

Abstract

A malignant tumor can cause hypercoagulation and it also often coexists with thrombosis. Cisplatin-based chemotherapy can also induce adverse vascular effects, including arterial thrombosis. We herein report a case of acute arterial thrombosis in a patient undergoing postoperative adjuvant cisplatin-based chemotherapy for completely resected lung cancer. The patient complained of acute leg pain after chemotherapy, and computed tomography revealed multiple thrombi from the thoracic to popliteal arteries. Arterial thrombosis during adjuvant chemotherapy is extremely rare; however, careful clinical observation of patients receiving cisplatin-based chemotherapy is important, because arterial thrombosis, even in the absence of the primary malignant tumor, is possible.

Keywords: arterial thrombosis; cisplatin; lung cancer; resected.

Publication types

  • Case Reports

MeSH terms

  • Acute Disease
  • Adenocarcinoma / drug therapy*
  • Adenocarcinoma / surgery
  • Adenocarcinoma of Lung
  • Aged
  • Antineoplastic Agents / adverse effects*
  • Antineoplastic Agents / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Chemotherapy, Adjuvant
  • Cisplatin / adverse effects*
  • Cisplatin / therapeutic use
  • Humans
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / surgery
  • Male
  • Pneumonectomy*
  • Popliteal Artery*
  • Postoperative Complications / chemically induced
  • Postoperative Complications / diagnosis
  • Thoracic Arteries*
  • Thrombosis / chemically induced*
  • Thrombosis / diagnosis

Substances

  • Antineoplastic Agents
  • Cisplatin